Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.07. | Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report | 260 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
01.07. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 263 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8... ► Artikel lesen | |
04.06. | ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics | 247 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) Euronext Growth: ALIKO, through its fully owned Italian subsidiary Hospitex International is pleased to announce the signing of an exclusive distribution... ► Artikel lesen | |
30.05. | Ikonisys SA: Ikonisys Announces a Further Postponement of the Publication of Its 2024 Annual Financial Report | 302 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
02.05. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through the Offsetting of Debt | 305 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
IKONISYS Aktie jetzt für 0€ handeln | |||||
25.04. | Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report | 267 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
03.04. | Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy | 330 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), announces that its Italian subsidiary Hospitex International has launched Urine24.com, the first online-available... ► Artikel lesen | |
10.03. | Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy | 267 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of Cytology medical devices and fully owned subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company... ► Artikel lesen | |
27.02. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through a Private Placement | 509 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
05.02. | Ikonisys' Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia | 482 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that its subsidiary Hospitex, the Italian leader in the production of medical devices, has secured... ► Artikel lesen | |
27.01. | Ikonisys Secures U.S. Patent for "Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments" | 388 | Business Wire | Regulatory News:
Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant... ► Artikel lesen | |
15.01. | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 284 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen | |
10.01. | Ikonisys SA: Ikonisys finalized a capital increase through the offsetting of debt | 354 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
31.12.24 | Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific | 470 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
04.12.24 | The Ikonisys Group Unveils its New Vision and Strategy Under the Brand "ALIKO SCIENTIFIC" | 568 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
25.11.24 | Ikonisys SA: Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy | 149 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
19.11.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 281 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
18.11.24 | Ikonisys SA: Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama | 428 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
12.11.24 | Ikonisys SA: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax's CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety | 466 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
04.11.24 | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | 629 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 47,240 | +0,90 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 49 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Die Phase steigender Markterwartungen sei bei... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,540 | +0,64 % | Siemens Healthineers-Aktie leicht im Minus (46,38 €) | Im Minus liegt gegenwärtig die Aktie von Siemens Healthineers . Der jüngste Kurs betrug 46,38 Euro. Am deutschen Aktienmarkt hat sich heute der Anteilsschein von Siemens Healthineers zwischenzeitlich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,320 | +0,79 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für die Aktien von FMC von 43,50 auf 38 Euro gesenkt und die Papiere von "Neutral" auf "Sell" abgestuft. Analyst Graham Doyle... ► Artikel lesen | |
CARL ZEISS MEDITEC | 41,320 | -0,10 % | Carl Zeiss Meditec-Aktie: Kurs fällt ab (43,30 €) | Im Minus liegt aktuell der Anteilsschein von Carl Zeiss Meditec . Die Aktie notiert zur Stunde bei 43,30 Euro. Die Carl Zeiss Meditec-Aktie verzeichnet derzeit einen Abschlag von 2,83 Prozent. Sie hat... ► Artikel lesen | |
GERRESHEIMER | 42,040 | +1,94 % | INDEX-MONITOR: Fraport, Nordex, Flatexdegiro im Stoxx 600 | FRANKFURT (dpa-AFX) - Zu den sieben im September neuen Unternehmen im Stoxx Europe 600 zählen auch drei deutsche. Zugleich werden aber auch drei deutsche Unternehmen den Index verlassen müssen. Von... ► Artikel lesen | |
BEYOND AIR | 3,190 | 0,00 % | Beyond Air, Inc. - 8-K, Current Report | ||
UNITEDHEALTH | 272,40 | 0,00 % | UnitedHealth Group-Aktie mit Kursgewinnen (266,65 €) | An der US-amerikanischen Börse liegt das Wertpapier der UnitedHealth Group aktuell im Plus. Der jüngste Kurs betrug 266,65 Euro. Ein Kursgewinn in Höhe von 2,80 Euro erfreut derzeit die Aktionäre der... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 25,470 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
HIMS & HERS HEALTH | 42,490 | +0,62 % | Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem | ||
GENEDX | 129,31 | -2,40 % | GeneDx stellt auf Wells Fargo Konferenz strategische Vision für Diagnostik vor | ||
ALIGNMENT HEALTHCARE | 16,220 | 0,00 % | Alignment Healthcare names Matt Eyles as EVP of government strategy | ||
ECKERT & ZIEGLER | 16,350 | +0,31 % | PTA-News: NWN Nebenwerte Nachrichten AG: Eckert & Ziegler - Radiopharmazie als Umsatztreiber - Die jüngste Kursschwäche könnte eine gute Gelegenheit für einen Einstieg sein | DJ PTA-News: NWN Nebenwerte Nachrichten AG: Eckert & Ziegler - Radiopharmazie als Umsatztreiber - Die jüngste Kursschwäche könnte eine gute Gelegenheit für einen Einstieg sein
Unternehmensmitteilung... ► Artikel lesen | |
DRAEGERWERK | 67,50 | +1,35 % | Drägerwerk: Solide Basis, klare Vision - eine Aktie für die Jahresendrallye? | Der Anbieter für Medizin- und Sicherheitstechnik ist trotz des Kursanstiegs günstig zu haben. Der hohe Auftragseingang spricht für ein starkes zweites Halbjahr. Von Philipp Roos. Was in der Vergangenheit... ► Artikel lesen | |
KINDLY MD | 4,550 | 0,00 % | KindlyMD, Inc: KindlyMD Subsidiary Nakamoto Makes First Investment in Foreign Publicly Listed Bitcoin Company with Netherlands-based Treasury | Treasury Intends to Reverse List on Euronext Amsterdam through Transaction with MKB Nedsense N.V. SALT LAKE CITY, UT / ACCESS Newswire / September 3, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD")... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 38,930 | 0,00 % | Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts |